Methods for diagnosing skin lesions are disclosed. Generally, the method include topically administering an IRM compound to a treatment area for a period of time and in an amount effective to cause a visible change in the appearance of a skin lesion including, in some cases, causing subclinical lesions to become visible. Suitable IRM compounds include agonists of one or more TLRs.
申请公布号
WO2004080293(A2)
申请公布日期
2004.09.23
申请号
WO2004US07946
申请日期
2004.03.12
申请人
3M INNOVATIVE PROPERTIES COMPANY
发明人
MILLER, RICHARD L.,;LEE, JAMES H.,;FOX, TERRANCE L.,